MannKind Stock Is Likely To Have A Strong Week
MannKind Corporation (NASDAQ: MNKD)
MannKind Corporation stock has struggled in the market recently due to an unfounded downgrade by Goldman Sachs and investor concern for sales of Afrezza. However, as doctors start to give feedback on the inhaled insulin, investors are starting to see the value in it over all. With that being said, I think we’re going to see a strong week from MNKD this week as more and more investors get in on the Afrezza action.
BG Medicine Stock Should Maintain Upward Momentum
BG Medicine, Inc. (NASDAQ: BGMD)
BG Medicine declared a landmark study ; causing the stock to climb. This week, I think we’ll see a continuation of this growth as investors jump in on the frenzy.
ZIOPHARM Oncology Stock Should Make Up For Last Week’s Losses
ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP)
ZIOPHARM Oncology had a tough week last week along with much of the biotech space. With poor economic data coming out on Wednesday, we saw US stocks fall dramatically. However, I think we’re going to see a change in pace overall this week; especially with ZIOP. This week, I’m expecting to see ZIOPHARM at least make up for the losses we saw last week, if not grow beyond the breaking point.
Amarin Corporation Stock May Bounce Back To Life
Amarin Corporation plc (ADR) (NASDAQ: AMRN)
After an analyst upgrade pushed Amarin stock up too much too fast, investors seemed to have gotten concerned and backed out quickly; sending AMRN on a long term downtrend. While the stock has struggled to gain positive momentum, I’m a big fan of Amarin as a company and it this point, think that the stock is relatively under valued. With that said, I think that this week will most likely be the week that we finally see the stock bounce back from the declines we’ve seen lately.
Intercept Pharmaceuticals Stock Will Climb As Well
Intercept Pharmaceuticals Inc (NASDAQ: ICPT)
Intercept Pharmaceuticals stock saw a nice increase in value toward the end of last week as Deutsche Bank increased the stock’s price target to $400; insinuating a strong outlook for the company. Moving into this week, the stock should rise as investors start to see their opportunity to get in on the gains.
What Do You Think?
Do you have an opinion on any of the stocks mentioned here? If so, we’d love to see it in the comments below!